Human monoclonal antibody against hepatitis c virus e2 glycoprotein

Human monoclonal antibody against hepatitis c virus e2 glycoprotein

Disclosed is a hybridoma cell line which produces human antibodies capable of binding to the hepatitis C virus (HCV) E2 glycoprotein and capable of neutralizing HCV infection in vivo in an animal model, as well as antibodies produced by the cell line. Also disclosed are various uses of said antibodi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Da Silva Cardoso, Marcia, Kubanek, Bernard, Sifmoneit, Karl, Dagan, Shlomo, Eren, Rachel
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Da Silva Cardoso, Marcia
Kubanek, Bernard
Sifmoneit, Karl
Dagan, Shlomo
Eren, Rachel
description Disclosed is a hybridoma cell line which produces human antibodies capable of binding to the hepatitis C virus (HCV) E2 glycoprotein and capable of neutralizing HCV infection in vivo in an animal model, as well as antibodies produced by the cell line. Also disclosed are various uses of said antibodies in the prevention and treatment of HCV infection. Peripheral blood lymphocytes obtained from human donors having a high titer of anti HCV E2 antibodies are transformed in vitro by Epstein-Barr virus and then fused with heteromyeloma cells to generate hybridomas secreting human antibodies having a high affinity and specificity to HCV E2 glycoprotein.
format Patent
fullrecord <record><control><sourceid>uspatents_EFI</sourceid><recordid>TN_cdi_uspatents_applications_20040071710</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20040071710</sourcerecordid><originalsourceid>FETCH-uspatents_applications_200400717103</originalsourceid><addsrcrecordid>eNqVjDEOwjAMALMwoMIfvDIgpQWpD6hAfQB7ZUIollI7qp1K_T0d-ADTLXe3d11fJmSYhCUkYUyAbPSU1wo4IrEafGJGIyOFAAvNRSE2MKY1SJ7FIvHB7d6YNB5_rNzpfnt0_bnoVkY2HTDnRGHbCOvQeH_1vq3b2l_-cb9lXTmv</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Human monoclonal antibody against hepatitis c virus e2 glycoprotein</title><source>USPTO Published Applications</source><creator>Da Silva Cardoso, Marcia ; Kubanek, Bernard ; Sifmoneit, Karl ; Dagan, Shlomo ; Eren, Rachel</creator><creatorcontrib>Da Silva Cardoso, Marcia ; Kubanek, Bernard ; Sifmoneit, Karl ; Dagan, Shlomo ; Eren, Rachel</creatorcontrib><description>Disclosed is a hybridoma cell line which produces human antibodies capable of binding to the hepatitis C virus (HCV) E2 glycoprotein and capable of neutralizing HCV infection in vivo in an animal model, as well as antibodies produced by the cell line. Also disclosed are various uses of said antibodies in the prevention and treatment of HCV infection. Peripheral blood lymphocytes obtained from human donors having a high titer of anti HCV E2 antibodies are transformed in vitro by Epstein-Barr virus and then fused with heteromyeloma cells to generate hybridomas secreting human antibodies having a high affinity and specificity to HCV E2 glycoprotein.</description><language>eng</language><creationdate>2004</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20040071710$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,869,881,64032</link.rule.ids><linktorsrc>$$Uhttps://patentcenter.uspto.gov/applications/10343015$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Da Silva Cardoso, Marcia</creatorcontrib><creatorcontrib>Kubanek, Bernard</creatorcontrib><creatorcontrib>Sifmoneit, Karl</creatorcontrib><creatorcontrib>Dagan, Shlomo</creatorcontrib><creatorcontrib>Eren, Rachel</creatorcontrib><title>Human monoclonal antibody against hepatitis c virus e2 glycoprotein</title><description>Disclosed is a hybridoma cell line which produces human antibodies capable of binding to the hepatitis C virus (HCV) E2 glycoprotein and capable of neutralizing HCV infection in vivo in an animal model, as well as antibodies produced by the cell line. Also disclosed are various uses of said antibodies in the prevention and treatment of HCV infection. Peripheral blood lymphocytes obtained from human donors having a high titer of anti HCV E2 antibodies are transformed in vitro by Epstein-Barr virus and then fused with heteromyeloma cells to generate hybridomas secreting human antibodies having a high affinity and specificity to HCV E2 glycoprotein.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2004</creationdate><recordtype>patent</recordtype><sourceid>EFI</sourceid><recordid>eNqVjDEOwjAMALMwoMIfvDIgpQWpD6hAfQB7ZUIollI7qp1K_T0d-ADTLXe3d11fJmSYhCUkYUyAbPSU1wo4IrEafGJGIyOFAAvNRSE2MKY1SJ7FIvHB7d6YNB5_rNzpfnt0_bnoVkY2HTDnRGHbCOvQeH_1vq3b2l_-cb9lXTmv</recordid><startdate>20040415</startdate><enddate>20040415</enddate><creator>Da Silva Cardoso, Marcia</creator><creator>Kubanek, Bernard</creator><creator>Sifmoneit, Karl</creator><creator>Dagan, Shlomo</creator><creator>Eren, Rachel</creator><scope>EFI</scope></search><sort><creationdate>20040415</creationdate><title>Human monoclonal antibody against hepatitis c virus e2 glycoprotein</title><author>Da Silva Cardoso, Marcia ; Kubanek, Bernard ; Sifmoneit, Karl ; Dagan, Shlomo ; Eren, Rachel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_applications_200400717103</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2004</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Da Silva Cardoso, Marcia</creatorcontrib><creatorcontrib>Kubanek, Bernard</creatorcontrib><creatorcontrib>Sifmoneit, Karl</creatorcontrib><creatorcontrib>Dagan, Shlomo</creatorcontrib><creatorcontrib>Eren, Rachel</creatorcontrib><collection>USPTO Published Applications</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Da Silva Cardoso, Marcia</au><au>Kubanek, Bernard</au><au>Sifmoneit, Karl</au><au>Dagan, Shlomo</au><au>Eren, Rachel</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Human monoclonal antibody against hepatitis c virus e2 glycoprotein</title><date>2004-04-15</date><risdate>2004</risdate><abstract>Disclosed is a hybridoma cell line which produces human antibodies capable of binding to the hepatitis C virus (HCV) E2 glycoprotein and capable of neutralizing HCV infection in vivo in an animal model, as well as antibodies produced by the cell line. Also disclosed are various uses of said antibodies in the prevention and treatment of HCV infection. Peripheral blood lymphocytes obtained from human donors having a high titer of anti HCV E2 antibodies are transformed in vitro by Epstein-Barr virus and then fused with heteromyeloma cells to generate hybridomas secreting human antibodies having a high affinity and specificity to HCV E2 glycoprotein.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_applications_20040071710
source USPTO Published Applications
title Human monoclonal antibody against hepatitis c virus e2 glycoprotein
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T08%3A10%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFI&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Da%20Silva%20Cardoso,%20Marcia&rft.date=2004-04-15&rft_id=info:doi/&rft_dat=%3Cuspatents_EFI%3E20040071710%3C/uspatents_EFI%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true